Zeo ScientifiX (ZEOX) Liabilities from Discontinued Operations (2014 - 2022)
Zeo ScientifiX (ZEOX) posted quarterly Liabilities from Discontinued Operations of 125851.0 for Q2 2022, little changed year-over-year from 125851.0 in Q2 2021, and little changed quarter-over-quarter from 125851.0 in Q1 2022.
Zeo ScientifiX (ZEOX) Liabilities from Discontinued Operations (2014 - 2022) Analysis & Trends
Zeo ScientifiX's Liabilities from Discontinued Operations history runs 9 years deep, the most recent figure standing at 125851.0 for Q2 2022.
- In Q2 2022, Liabilities from Discontinued Operations changed 0.0% year-over-year to 125851.0; the TTM figure through Apr 2022 stood at 125851.0 (changed 0.0% YoY), while the FY2021 annual figure was 125851.0, changed 0.0% from the prior year.
- Liabilities from Discontinued Operations for Q2 2022 stood at 125851.0, roughly flat from 125851.0 in the prior quarter.
- The five-year high for Liabilities from Discontinued Operations was 125851.0 in Q1 2018, with the low at 125851.0 in Q1 2018.
- The 5-year median for Liabilities from Discontinued Operations is 125851.0 (2018), against an average of 125851.0.
- Peak annual rise in Liabilities from Discontinued Operations reached 0.0% in 2018, while the deepest fall reached 0.0% in 2018.
- Zeo ScientifiX's Liabilities from Discontinued Operations stood at 125851.0 in 2018, then changed by 0.0% to 125851.0 in 2019, then changed by 0.0% to 125851.0 in 2020, then changed by 0.0% to 125851.0 in 2021, then changed by 0.0% to 125851.0 in 2022.
- Business Quant data shows ZEOX's Liabilities from Discontinued Operations at 125851.0 in Q2 2022, 125851.0 in Q1 2022, and 125851.0 in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2022 | 125,851.00 |
| Apr 30, 2022 | 125,851.00 |
| Jan 31, 2022 | 125,851.00 |
| Jan 31, 2022 | 125,851.00 |
| Oct 31, 2021 | 125,851.00 |
| Oct 31, 2021 | 125,851.00 |
| Jul 31, 2021 | 125,851.00 |
| Jul 31, 2021 | 125,851.00 |
| Apr 30, 2021 | 125,851.00 |
| Apr 30, 2021 | 125,851.00 |
| Jan 31, 2021 | 125,851.00 |
| Jan 31, 2021 | 125,851.00 |
| Oct 31, 2020 | 125,851.00 |
| Oct 31, 2020 | 125,851.00 |
| Jul 31, 2020 | 125,851.00 |
| Jul 31, 2020 | 125,851.00 |
| Apr 30, 2020 | 125,851.00 |
| Apr 30, 2020 | 125,851.00 |
| Jan 31, 2020 | 125,851.00 |
| Jan 31, 2020 | 125,851.00 |